SCHEMBL2363861

SCHEMBL2363861

N#CC(Cn1cc(-c2ccnc(Nc3cccc(N)c3)n2)cn1)C1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 4/20 0.49
▸ BCR P11274 4/20 0.49
▸ SRC P12931 3/20 0.49
▸ EGFR P00533 1/20 0.49
▸ PRKACA P17612 1/20 0.49
▸ PRKACG P22612 1/20 0.49
▸ PRKACB P22694 1/20 0.49
▸ JAK2 O60674 2/20 0.47
▸ JAK1 P23458 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ STAT3 P40763 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ CDK5 Q00535 2/20 0.45
▸ CAMK2D Q13557 2/20 0.44
▸ IKBKE Q14164 6/20 0.42
▸ TBK1 Q9UHD2 6/20 0.42
▸ MAP3K14 Q99558 1/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ CDK4 P11802 1/20 0.40
▸ CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3375492 0.85 MTOR (0.48) ABL1BCRSRCJAK2JAK1
SCHEMBL3301729 0.81 JAK2 (0.54) ABL1BCRSRCEGFRPRKACA
SCHEMBL3377981 0.79 SYK (0.43) ABL1BCRSRCJAK2JAK1
SCHEMBL13846245 0.79 ABL1 (0.53) ABL1BCRSRCEGFRPRKACA
SCHEMBL3378327 0.77 NTRK1 (0.42) ABL1BCRSRCJAK2JAK1
SCHEMBL2363857 0.76 ABL1 (0.48) ABL1BCRSRCEGFRPRKACA
SCHEMBL2363859 0.72 ABL1 (0.48) ABL1BCRSRCEGFRPRKACA
SCHEMBL2358226 0.71 CCNE1 (0.57) ABL1PRKACAJAK2JAK1TYK2
SCHEMBL3374818 0.71 PRKCQ (0.43) ABL1EGFRJAK2JAK1TYK2
SCHEMBL2356289 0.71 JAK2 (0.58) ABL1EGFRPRKACAJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349260-A1 JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES Incyte Corporation (US) 2011-08-03 — — EP disclosed
WO-2010039939-A1 JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES INCYTE CORPORATION (US) 2010-04-08 — — WO disclosed
Send feedback